Objective: To determine whether decreased cardiac responsiveness to isoproterenol in obesity is associated with alterations in b-receptors and=or adenylyl cyclase activity. Animals and Design: After 12 weeks of control or ad libitum high-fat diets, left ventricular tissue from lean and obese female New Zealand white rabbits was assayed for b-receptor binding density (11 lean, 11 obese) and isoproterenol-stimulated adenylyl cyclase activity (eight lean, 10 obese). Measurements: Nonlinear least squares regression analysis was used to determine maximum density of b-receptors and receptor affinity for 125 I-iodocyanopindolol. Four-parameter logistic regression was used to determine minimum, maximum, slope and EC 50 for isoproterenol-stimulated adenylyl cyclase activity. Results: Obese rabbits had elevated resting blood pressure and heart rate, and higher ventricular weights. However, badrenoceptor density and affinity were not significantly different in lean and obese rabbits. Basal and maximum isoproterenolstimulated adenylyl cyclase activity did not differ between lean and obese rabbits. In addition, maximal stimulation in response to sodium flouride did not differ between lean and obese. EC 50 for isoproterenol-stimulated adenylyl cyclase activity did not differ between lean and obese rabbits. Conclusion: Obesity-related decreases in responsiveness of the isolated heart to isoproterenol are not associated with alterations in b-receptor density and affinity. In addition, adenylyl cyclase activity appeared unchanged in ventricular preparations from obese rabbits. Decreased responsiveness to isoproterenol in obesity may be due to defects downstream of adenylyl cyclase activation of cyclic AMP.
Introduction
Obesity is associated with decrements in diastolic and systolic function and obese individuals are at increased risk for developing congestive heart failure. Decrements in systolic function in obesity include lower ejection fraction, peak ejection rate and fractional shortening, and higher end systolic diameter. 1, 2 Even in the absence of hypertension, cardiac hypertrophy, a hyperkinetic circulation, and reduced cardiac function have been documented in obese humans. 1, 3, 4 Further, the Framingham study has determined that obesity is an independent risk factor for congestive heart failure. 5 This suggests that pathologic changes in cellular cardiac function occur during the development of obesity resulting in impaired left ventricular systolic performance.
Yet few studies have addressed basic mechanisms of systolic dysfunction in obesity, such as alterations in b-receptor signaling. Most studies have been in rodent models and results have been conflicting. Density of b-receptors has been shown to be either unchanged 6, 7 or decreased; 7 -9 receptor affinity for agonist generally was unchanged, 6 -8 although one study did find a decrease. 7 Obesity in rat models was associated with decreased adenylyl cyclase activity, 7, 8, 10 while in obese mouse models it was not. 8 However, obesity in rodent models is genetically determined and often occurs in the absence of many of the hallmark changes seen in human obesity, such as hypertension, cardiac hypertrophy and elevated intravascular volumes.
Using the rabbit model of dietary-induced obesity, which mimics many of the characteristics of human obesity, 11 we previously demonstrated a reduced responsiveness to isoproterenol in both the isolated heart and isolated papillary muscle preparations. 12 We also found a reduced contractile response to forskolin in the isolated hearts of obese rabbits. 13 Taken together, these studies suggested that obesity in this model was associated with one or more defects in b-receptor second messenger signaling system. However, neither of these studies was designed to determine what alterations in the signaling cascade were responsible for the obesity-related decrease in function. While the decreased response to forskolin suggests a defect at or after the activation of adenylyl cyclase, the decreased response to isoproterenol suggests that a defect at the level of the receptor cannot be ruled out. Therefore, the present study determined b-receptor density (B max ) and affinity (K d ), as well as b-adrenoceptor-dependent adenylyl cyclase activity in cardiac membrane preparations from lean and obese rabbits.
Methods

Animals
Experimental protocols for this study were approved by the Institutional Animal Care and Use Committee of the University of North Texas Health Science Center. All animal care and use programs were carried out according to the Guide for the Care and Use of Laboratory Animals (NIH Publication 86-23, revised 1985) and the regulations of the Animal Welfare Act. Female New Zealand White rabbits were purchased when they were approximately 15 -17 weeks old weighing 3.25 -3.75 kg (Myrtle's Rabbitry, Thompson Station, TN, USA). They were housed individually in a humidity and temperature controlled room with a 12 h light cycle and fed 100 -120 g per day of standard rabbit chow (Prolab 1 Breeder Rabbit chow, Purina Mills, St Louis, MO, USA). After a 1-week acclimation period they were randomly divided into two groups, one designated to remain lean and the other to become obese. The lean group continued with a maintenance diet. The obese group was given a high fat diet, ad libitum, which consisted of the standard rabbit chow with 10% added fat. The excess fat in the diet was twothirds corn oil and one-third lard. Composition of the standard rabbit chow is 16.2% protein, 2.5% fat, 14.0% fiber and 50.5% carbohydrate, while composition of the high fat diet is 14.6% protein, 12.3% fat, 12.6% carbohydrate and 44.0% carbohydrate (balance moisture and ash). Experiments were performed after the rabbits had been on their respective diets for 12 weeks.
Blood pressure measurement
On the day of the experiment the rabbit was restrained in a Plexiglas holder (Plas Labs, Lansing, MI, USA). The central auricular artery was cannulated (PE-50 tubing) using 0.25% bupivacaine as a local anesthetic. The rear and neck restraints were loosened and the rabbit was allowed to sit quietly for 60 to 90 min. Blood pressure was recorded directly from the arterial catheter using a disposable pressure transducer positioned at heart level. The signal from the transducer was amplified and sent to an analog-to-digital (A=D) converter in a personal computer. Data were collected using commercial software (Micro-Med, Louisville, KY, USA). Briefly, the signal to the A=D converter was continuously sampled at 500 Hz and processed to detect systolic, diastolic and mean pressures as well as heart rate. Data were averaged every 10 s and saved to disk for later analysis. Reported values were taken during the last half-hour of recording while the rabbit was in a quiet, resting state. After blood pressure measurement, general anesthesia was induced with 4 -5% isoflurane with an oxygen flow of 1 l=min administered with a face-mask. The heart was then subjected to cardioplegic arrest by blocking venous return through the vena cavae and infusing cold (4 C) Euro-Collins solution retrograde into the aortic root.
b-receptor binding assay Tissue preparation. After isolated heart perfusion, portions of left ventricle were dissected, homogenized with a Polytron (4Â10 s, setting 7) in 10 ml of homogenization buffer (50 mM Tris -HCl, pH 7.4, 4 C, 0.32 M sucrose), and stored at 7 90 C until processing. In a subset of rabbits, portions of the right ventricle were similarly prepared. At the time of assay, the homogenate was filtered through nylon mesh and centrifuged at 40,000 g for 20 min. The resulting crude membrane pellet was resuspended in homogenization buffer, homogenized (Polytron, 10 s, setting 7), and recentrifuged at 40,000Âg for 20 min. The washed membrane pellet was resuspended in HE buffer (10 mM HEPES, 0.1 mM EGTA, pH 7.4) at a concentration of 0.13 g wet weight=ml and homogenized in a glass=Teflon homogenizer for 10 strokes.
Assay. Washed ventricular membranes ( $ 5 mg protein) were diluted 1:10 with HE buffer for assay; membranes were then incubated in a final volume of 200 ml of HE buffer with 12 increasing concentrations (5 -200 pM) 125 Iiodocyanopindolol (I-CYP; 2200 Ci=mmol; NEN Life Science Products) for 60 min at 37 C. A parallel set of tubes contained 1mM S-( 7 )-propranolol for determination of nonspecific binding. Binding reactions were terminated by rapid addition of 10 ml of ice-cold wash buffer (10 mM Tris-HCl, 0.154 M NaCl, pH 7.4) followed by rapid filtration through glass fiber filters (Schleicher & Schuell, no. 30). Filters were washed with an additional 10 ml of wash buffer and filterbound radioactivity determined using a gamma scintillation spectrometer at 85% efficiency. All assays were conducted in triplicate. Specific binding was defined as the difference between total binding in the absence of propranalol and nonspecific binding in the presence of 10 76 M propranolol.
b-Receptors and adenylyl cyclase in obese rabbits JF Carroll et al Protein concentrations were determined using BCA reagent (Pierce) and bovine gamma globulin as a standard.
Adenylyl cyclase assay Tissue preparation. In separate groups of animals, hearts were removed rapidly, rinsed several times in ice-cold EuroCollins solution, and connective tissue, aorta, and atria removed. The left ventricle was frozen in liquid nitrogen and stored at 7 80 C. On the day of the experiment, left ventricular tissue was weighed, minced and rapidly homogenized with a Polytron (3Â10 s, setting 70%) in 20 vol of homogenization buffer (50 mM Tris -HCl, pH 7.4, 4 C, 0.32 M sucrose). The homogenate was filtered through nylon mesh and centrifuged at 40 000 g for 20 min. The resulting crude membrane pellet was resuspended in homogenization buffer, recentrifuged, and the resulting pellet resuspended in 50 mM NaHepes, pH 7.4, 4
C at a concentration of 50 mg wet weight=ml. Protein concentrations were determined using BCA reagent (Pierce) and bovine gamma globulin as a standard.
Assay. The conversion of [a P]-cyclic AMP by washed membrane preparations was measured using a modification of the method originally described by Salomon. 14 We compared basal left ventricular adenylyl cyclase activity to that obtained after the addition of 10 mm GTP, NaF and increasing concentrations of isoproterenol (10 79 -10 75 M).
All concentrations were assayed in triplicate. Assays were initiated by the addition of 20 ml of membranes (20 -50 mg protein) to a solution containing the following reagents (final concentrations) in an assay volume of 100 ml: 50 mM HEPES (pH 7.4), 5 mM MgCl 2 , 1 mM dithiothreitol, 0.1 mg=ml bovine serum albumin, 0.1 mM EGTA, 0.1 mM 3-isobutylmethyl-xanthine, 0.05 mM cyclic AMP; 0.1 mM ATP, 1.5Â10 6 cpm of [a 32 P]-ATP, 50 units=ml creatine phosphokinase; and 5 mM phosphocreatine. Isoproterenol was dissolved in 0.1% (w=v) ascorbic acid. Incubations were carried out for 15 min, 30 C. Reactions were terminated by the addition of 100 ml of a solution containing 2% SDS, 4.5 mM ATP, 1 mM 3 H-cyclic AMP (50 m1, 10 000 cpm, to monitor column recovery) and 50 mM Tris (pH 7.5). Membranes were solubilized in a boiling water bath for 3 min and the volumes were brought to 1 ml with H 2 O. 
Data analysis
For determination of the maximum density of b-receptors (B max ) and receptor affinity for 125 I-CYP (K d ), data were fit to a model of mass action binding to either a single or multiple binding sites using computer-assisted nonlinear least squares regression analysis. 15 In order to understand the possible effect of increased ventricular weight in obesity on receptor density, receptor density was expressed as fmol=mg membrane protein, pmol=g wet ventricular weight and pmol=ventricle.
Adenylyl cyclase activity in response to increasing concentrations of isoproterenol was analyzed with non-linear regression analysis of the data using a four-parameter logistic equation 16 (Table Curve 1 , Jandel Scientific). Minimum, maximum, EC 50 , and slope parameters were determined for each sample.
Group means of descriptive data (ie, body weight, resting blood pressure and heart rate and ventricular weights), B max and K d , and parameters determined for adenylyl activity (ie minimum, maximum, EC 50 and slope) were compared using unpaired t-tests. Group means were accepted as statistically different when P 0.05.
Results
Animal characteristics
In the b-receptor and adenylyl cyclase experiments, rabbits fed the high-fat diet for 12 weeks were 48 and 45% heavier, respectively, than the control-fed rabbits. In addition, obese rabbits exhibited elevated resting blood pressure and heart, as well as left and right ventricular weights, compared with their lean counterparts ( Table 1) .
b-receptor density and affinity
Although average receptor density (B max ) in obese rabbits was higher by 20% (Table 2) , this was not significantly greater than in lean rabbits. B max calculated as pmol=gram of wet ventricular weight was increased in obese rabbits by a similar percentage (17%), but was not significantly different from lean rabbits. B max calculated as pmol=ventricle was significantly greater in obese compared with lean rabbits. Adenylyl cyclase activity Unstimulated adenylyl cyclase activity, ie measured in the absence of GTP (57.5 AE 9.1 vs 54.5 AE 6.2 pmol=min=mg, respectively), and basal enzyme activity measured in the presence of 10 mM GTP (65.0 AE 9.5 vs 62.0 AE 9.8 pmol=min= mg, respectively), were not significantly different in ventricular membranes obtained from lean and obese animals. In addition, maximal stimulation in response to NaF did not differ between lean and obese rabbits (Table 3) . Thus, there was no indication that adenylyl cyclase activity per se differed in lean and obese. Likewise, there was no significant difference between lean and obese in receptor-dependent stimulation of adenylyl cyclase activity. The sensitivity of the receptor to agonist stimulation was unchanged as reflected by similar EC 50 values for isoproterenol-dependent stimulation (Table 3) . Results from a typical adenylyl cyclase activity assay are illustrated in Figure 2 .
Discussion
The primary findings of the present study were twofold. First, obese rabbits did not demonstrate differences in b-adrenoceptor density (B max ) or affinity (K d ) in either left or right ventricular tissue. In addition, neither the basal nor the NaFstimulated ventricular adenylyl cyclase activity differed between lean and obese rabbits, suggesting that adenylyl cylcase activity per se was unchanged. The coupling of the badrenoceptor to adenylyl cylcase activation was also unaltered since the EC 50 for isoproterenol and the maximal isopreterenol-dependent stimulation of enzyme activity were not significantly different in ventricular membranes from lean and obese animals. This characterization of two aspects of the b-receptor signaling system in obesity occurred in the context of hypertension, resting tachycardia and ventricular hypertrophy.
Previously we noted that both isolated hearts and isolated papillary muscles of obese rabbits had reductions in isoproterenol-stimulated developed pressure=tension. 12 In addition, we have also noted reductions in peak forskolin- b-Receptors and adenylyl cyclase in obese rabbits JF Carroll et al stimulated developed pressure, peak þ dP=dt and 7 dP=dt in isolated hearts of obese rabbits. 13 These results suggested that there is at least one post-adenylyl cyclase defect in the breceptor signaling pathway in obesity, but they did not rule out alterations at the receptor level. Therefore, we studied two components of this pathway: b-receptor density and coupling of the receptor to activation of cAMP formation.
Our results suggest that previously reported 12 reductions in isoproterenol-stimulated function of the isolated heart in obesity are not due to reduced receptor density. This is in general agreement with data from obese SHR and JCR:LA-cp rat strains, which also showed no alterations in receptor density or ligand affinity. 6, 7 In contrast, obese-hypertensive SHHF=Mcc-cp rats demonstrated reduced B max and K d . 7 Similarly, obese Zucker rats exhibited decreased b-receptor density with unchanged affinity, 8, 9 associated with reduced coupling between the receptor and the G sa protein. 8 These differences were ascribed to either genetic influences, 7 or to metabolic differences such as the occurrence of frank diabetes in combination with obesity. 8 Varied results are also seen in studies of downstream components of the b-receptor signaling system in obesity. Obese diabetic mouse strains showed no reduction in adenylyl cyclase activity while obese Zucker rats demonstrated reduced activity. 8, 10 JCR:LA-cp obese rats also demonstrated reduced cAMP content in comparison to lean rats, but the combination of obesity and hypertension in SHHR=Mcc-cp rats resulted in even lower cAMP content. 7 In contrast, the combination of obesity and hypertension in the present study using a model of dietary-induced obesity did not result in alterations in basal and maximum isoproterenolstimulated adenylyl cyclase activity.
The discrepancies in these studies may arise from other factors, alone or in combination, such as species, primary genetic influences, the severity or duration of obesity, the simultaneous occurrence of hypertension, the severity or duration of hypertension, the presence of concentric or eccentric hypertrophy, or hormonal, metabolic or hemodynamic changes. The obese rabbit model is distinctive among obese animal models in that obesity is dietary-induced rather than genetic. Consistent with the human obese condition, the obese rabbit exhibits hypertension, cardiac hypertrophy, hyperinsulinemia, hyperglycemia and increased serum lipid levels. 11 In addition, cardiac output is elevated and total peripheral resistance reduced. 17 Thus, this model may provide unique opportunities to study cardiac function in a context similar to that seen in the human obesity.
Several hypotheses have arisen to explain altered b-receptor signaling function in obesity. These include the influence of volume overload on cardiac function, the added influence of hypertension, and downregulation of receptor function due to high circulating catecholamines. While volume overload could have influenced cardiac b-receptor pathway function in obese rats, 9 data from our model suggests that this is not the case. Obese rabbits have demonstrated a 37% increase in resting cardiac output 17 as well as a significant 16% increase in blood volume (274 AE 9 and 236 AE 8 ml, respectively, for obese and lean rabbits; unpublished data). Yet obese rabbits demonstrated no change in receptor density or ligand affinity, or in adenylyl cyclase activity. It has also been suggested that decreased receptor density 18 and=or affinity 19 were due to chronic exposure to high concentrations of sympathetic neurotransmitter, resulting in down-regulation and=or desensitization of the receptor. Conversely, increased receptor density may result from lower plasma and=or tissue catecholamine levels. In general agreement with this conclusion, we previously demonstrated that plasma catecholamines did not differ between lean and obese rabbits, 11 while the present study showed no obesityrelated alterations in b-receptor density=affinity. While a single measurement of plasma catecholamines does not adequately reflect the chronic state of the sympathetic nervous system or local cardiac sympathetic stimulation, it may suggest that the overall sympathetic drive in the rabbit model of obesity is not sufficiently altered to impact cardiac b-receptor density.
Interestingly, we did not find that obesity-related cardiac hypertrophy resulted in a 'dilution' effect 7 on the receptor, since the B max =ventricle was significantly greater in obese than in lean. In fact, the B max =ventricle in the obese was proportionally greater (65%) than the increase in left ventricular weight (37%) due to slightly, but nonsignificantly, higher B max =mg protein and B max =g wet weight combined with great ventricular weight. Nevertheless, our previous report 12 would suggest that the increase in B max =ventricle did not enhance function.
In summary, obesity in the rabbit model did not significantly alter cardiac b-adrenoceptor density or affinity. Further, both adenylyl cylcase activity per se and coupling of the b-adrenoceptor to adenylyl cylcase activation were also unaltered in obesity. These results, taken together with our previous studies 12, 13 suggest that there is at least one defect in the b-receptor signaling system occurring subsequent to adenylyl cyclase activation.
